These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 27507538)

  • 1. MiR-31 and miR-128 regulates poliovirus receptor-related 4 mediated measles virus infectivity in tumors.
    Geekiyanage H; Galanis E
    Mol Oncol; 2016 Nov; 10(9):1387-1403. PubMed ID: 27507538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus.
    Noyce RS; Bondre DG; Ha MN; Lin LT; Sisson G; Tsao MS; Richardson CD
    PLoS Pathog; 2011 Aug; 7(8):e1002240. PubMed ID: 21901103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles Virus Enters Breast and Colon Cancer Cell Lines through a PVRL4-Mediated Macropinocytosis Pathway.
    Delpeut S; Sisson G; Black KM; Richardson CD
    J Virol; 2017 May; 91(10):. PubMed ID: 28250131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles virus selectively blind to signaling lymphocyte activation molecule as a novel oncolytic virus for breast cancer treatment.
    Sugiyama T; Yoneda M; Kuraishi T; Hattori S; Inoue Y; Sato H; Kai C
    Gene Ther; 2013 Mar; 20(3):338-47. PubMed ID: 22717740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tumor-associated marker, PVRL4 (nectin-4), is the epithelial receptor for morbilliviruses.
    Delpeut S; Noyce RS; Richardson CD
    Viruses; 2014 Jun; 6(6):2268-86. PubMed ID: 24892636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of PVRL4, a molecular target for cancer treatment, is transcriptionally regulated by FOS.
    Nanamiya T; Takane K; Yamaguchi K; Okawara Y; Arakawa M; Saku A; Ikenoue T; Fujiyuki T; Yoneda M; Kai C; Furukawa Y
    Oncol Rep; 2024 Jan; 51(1):. PubMed ID: 38063270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wild-type measles virus infection upregulates poliovirus receptor-related 4 and causes apoptosis in brain endothelial cells by induction of tumor necrosis factor-related apoptosis-inducing ligand.
    Abdullah H; Brankin B; Brady C; Cosby SL
    J Neuropathol Exp Neurol; 2013 Jul; 72(7):681-96. PubMed ID: 23771216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-mediated multi-tissue detargeting of oncolytic measles virus.
    Baertsch MA; Leber MF; Bossow S; Singh M; Engeland CE; Albert J; Grossardt C; Jäger D; von Kalle C; Ungerechts G
    Cancer Gene Ther; 2014 Sep; 21(9):373-80. PubMed ID: 25145311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for PVRL4-driven cell-cell interactions in tumorigenesis.
    Pavlova NN; Pallasch C; Elia AE; Braun CJ; Westbrook TF; Hemann M; Elledge SJ
    Elife; 2013 Apr; 2():e00358. PubMed ID: 23682311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer.
    Hu Y; Qiu Y; Yagüe E; Ji W; Liu J; Zhang J
    Cell Death Dis; 2016 Jun; 7(6):e2291. PubMed ID: 27362808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles virus infection of epithelial cells in the macaque upper respiratory tract is mediated by subepithelial immune cells.
    Ludlow M; Lemon K; de Vries RD; McQuaid S; Millar EL; van Amerongen G; Yüksel S; Verburgh RJ; Osterhaus AD; de Swart RL; Duprex WP
    J Virol; 2013 Apr; 87(7):4033-42. PubMed ID: 23365435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles virus induces oncolysis of mesothelioma cells and allows dendritic cells to cross-prime tumor-specific CD8 response.
    Gauvrit A; Brandler S; Sapede-Peroz C; Boisgerault N; Tangy F; Gregoire M
    Cancer Res; 2008 Jun; 68(12):4882-92. PubMed ID: 18559536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measles virus selectively blind to signaling lymphocyte activity molecule has oncolytic efficacy against nectin-4-expressing pancreatic cancer cells.
    Awano M; Fujiyuki T; Shoji K; Amagai Y; Murakami Y; Furukawa Y; Sato H; Yoneda M; Kai C
    Cancer Sci; 2016 Nov; 107(11):1647-1652. PubMed ID: 27561180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graphene oxide arms oncolytic measles virus for improved effectiveness of cancer therapy.
    Xia M; Luo D; Dong J; Zheng M; Meng G; Wu J; Wei J
    J Exp Clin Cancer Res; 2019 Sep; 38(1):408. PubMed ID: 31533779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects.
    Msaouel P; Opyrchal M; Dispenzieri A; Peng KW; Federspiel MJ; Russell SJ; Galanis E
    Curr Cancer Drug Targets; 2018; 18(2):177-187. PubMed ID: 28228086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme.
    Phuong LK; Allen C; Peng KW; Giannini C; Greiner S; TenEyck CJ; Mishra PK; Macura SI; Russell SJ; Galanis EC
    Cancer Res; 2003 May; 63(10):2462-9. PubMed ID: 12750267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA regulation of progesterone receptor in breast cancer.
    Gilam A; Shai A; Ashkenazi I; Sarid LA; Drobot A; Bickel A; Shomron N
    Oncotarget; 2017 Apr; 8(16):25963-25976. PubMed ID: 28404930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-564 is downregulated in glioblastoma and inhibited proliferation and invasion of glioblastoma cells by targeting TGF-β1.
    Jiang C; Shen F; Du J; Hu Z; Li X; Su J; Wang X; Huang X
    Oncotarget; 2016 Aug; 7(35):56200-56208. PubMed ID: 27621042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme.
    Liu C; Sarkaria JN; Petell CA; Paraskevakou G; Zollman PJ; Schroeder M; Carlson B; Decker PA; Wu W; James CD; Russell SJ; Galanis E
    Clin Cancer Res; 2007 Dec; 13(23):7155-65. PubMed ID: 18056196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered measles virus as a novel oncolytic therapy against prostate cancer.
    Msaouel P; Iankov ID; Allen C; Morris JC; von Messling V; Cattaneo R; Koutsilieris M; Russell SJ; Galanis E
    Prostate; 2009 Jan; 69(1):82-91. PubMed ID: 18973133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.